Admission Glucose ICU Study

This study has been completed.
Sponsor:
Information provided by:
Park Nicollet Institute
ClinicalTrials.gov Identifier:
NCT00569322
First received: December 5, 2007
Last updated: December 6, 2007
Last verified: September 2007
  Purpose

Determine if routine BG testing at the time of ICU admission is being done on all patients, irrespective of a prior diagnosis of diabetes mellitus, and whether it provides clinically important information.


Condition Intervention
Hyperglycemia
Procedure: BG Test

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Evaluation of Admission Blood Glucose Levels in the Intensive Care Unit

Resource links provided by NLM:


Further study details as provided by Park Nicollet Institute:

Study Start Date: December 2003
Study Completion Date: September 2004
Detailed Description:

This prospective, observational study was performed in the medical-surgical ICU of a single hospital within a large multi-specialty healthcare system.

It was determined that it was not standard care to do glucose testing on all patients admitted to medical/surgical ICU's who did not have diagnosed diabetes and varied widely with the admitting service.

The primary objective of the study was to assess the availability and clinical value of blood glucose testing at the time of ICU admission after testing was implemented as routine care in the ICU.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • ICU Admission

Exclusion Criteria:

  • < 18 years of age
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00569322

Locations
United States, Minnesota
Methodist Hospital - Park Nicollet Health Services
Minneapolis, Minnesota, United States, 55416
Sponsors and Collaborators
Park Nicollet Institute
Investigators
Principal Investigator: Lisa H Fish, MD International Diabetes Center - Park Nicollet Health Services
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00569322     History of Changes
Other Study ID Numbers: 01817-03-C
Study First Received: December 5, 2007
Last Updated: December 6, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by Park Nicollet Institute:
ICU
Admission
BG

Additional relevant MeSH terms:
Hyperglycemia
Glucose Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on September 30, 2014